Based on the review on Rem, GIlead has many reasons to team up with us. The potential negative impact of Rem on Covid patients will have a long lasting damaging effect on Gilead image. If Leronlimab together with Rem can help patients to recover faster and keep Rem usage to only a few days, it will actually keep Gilead from going into the rabbit hole. Now if Gilead is really the invisible hand behind FDA, this move by NP can actually push FDA to approve Leronlimab faster.